Eli Lilly reports an increase in pharma sales and decline in Animal Health. Lifts 2018 earnings outlook.
When answering an analyst question, Enrique Conterno said, "We continue to see pressure on pricing across all of our diabetes products".
When answering an analyst question, Enrique Conterno said, "We continue to see pressure on pricing across all of our diabetes products".